Two new drugs for Parkinson's just hit the market

    Two new drugs for Parkinson's just hit the market...ropinirole (Requip, SmithKline Beecham) and tolcapone (Tasmar, Roche).

    Requip is a second-generation dopamine agonist.

    It's more selective for dopamine than the first generation agonists...Permax (pergolide) and Parlodel (bromocriptine).

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote